Multimorbidity in people with chronic kidney disease: Implications for outcomes and treatment

Current Opinion in Nephrology and Hypertension

Volumn 25, Issue 6, 2016, Pages 465-472

  Fraser, Simon D S ^a   Taal, Maarten W ^b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

chronic kidney disease; multimorbidity; polypharmacy; treatment burden

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY ASSESSMENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORTALITY; PATIENT-REPORTED OUTCOME; POLYPHARMACY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; MULTIPLE CHRONIC CONDITIONS; SELF CARE;

HUMANS; MULTIMORBIDITY; PATIENT REPORTED OUTCOME MEASURES; POLYPHARMACY; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; SELF CARE;

EID: 84982823079     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000270     Document Type: Review

References (36)

1. Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: Results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010; 55:S23-S33.
2. SD, Roderick PJ, May C, et al. The burden of comorbidity in people with chronic kidney disease stage 3: A cohort study. BMC Nephrol 2015; 16:193.
3. M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int 2015; 88:859- 866. First large population-based study examining comorbidity in people with CKD and emphasizing the impact of both concordant and discordant comorbid conditions on adverse outcomes.
4. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for healthcare, research, and medical education: A cross-sectional study. Lancet 2012; 380:37-43.
5. May CR, Eton DT, Boehmer K, et al. Rethinking the patient: Using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res 2014; 14:281.
6. Shippee ND, Shah ND, May CR, et al. Cumulative complexity: A functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol 2012; 65:1041-1051.
7. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res 2005; 40:1918-1930.
8. Stevens PE, Lamb EJ, Levin A. Integrating guidelines, CKD, multimorbidity, and older adults. Am J Kidney Dis 2015; 65:494-501.
9. Blakeman T, Protheroe J, Chew-Graham C, et al. Understanding the management of early-stage chronic kidney disease in primary care: A qualitative study. Br J Gen Pract 2012; 62:e233-e242.
10. Mucsi I, Kovacs AZ, Molnar MZ, Novak M. Co-morbidity and quality of life in chronic kidney disease patients. J Nephrol 2008; 21 (Suppl):S84-S91.
11. Fraser SDS, Roderick PJ, May C, et al. The burden and survival implications of comorbidity in people with chronic kidney disease stage 3. Nephrol Dial Transplant 2015; 30 (Suppl):iii185-iii186.
12. Jansen DL, Heijmans MJ, Rijken M, et al. Illness perceptions and treatment perceptions of patients with chronic kidney disease: Different phases, different perceptions?. Br J Health Psychol 2013; 18:244-262.
13. Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 2012; 9:e1001307.
14. A, King MA, Whitty JA, et al. Burden of treatment for chronic illness: A concept analysis and review of the literature. Health Expect 2015; 18:312- 324.
15. LS, Vest BM, Madurai N, et al. Chronic kidney disease (CKD) treatment burden among low-income primary care patients. Chronic Illn 2015; 11:171- 183.
16. Eton DT, Ramalho de Oliveira D, Egginton JS, et al. Building a measurement framework of burden of treatment in complex patients with chronic conditions: A qualitative study. Patient Relat Outcome Meas 2012; 3:39-49.
17. Tran VT, Harrington M, Montori VM, et al. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an Internet platform. BMC Med 2014; 12:109.
18. Tran VT, Montori VM, Eton DT, et al. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med 2012; 10:68.
19. DT, Ridgeway JL, Egginton JS, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Relat Outcome Meas 2015; 6:117-126.
20. Ridgeway JL, Egginton JS, Tiedje K, et al. Factors that lessen the burden of treatment in complex patients with chronic conditions: A qualitative study. Patient Prefer Adherence 2014; 8:339-351.
21. Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: Correlates and evolution over time. Clin J Am Soc Nephrol 2009; 4:1293-1301.
22. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis 2005; 45:658-666.
23. Soni RK, Porter AC, Lash JP, Unruh ML. Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis 2010; 17:e17-e26.
24. Walker AE. Multiple chronic diseases and quality of life: Patterns emerging from a large national sample. Australia Chronic Illn 2007; 3:202-218.
25. Abdel-Kader K, Myaskovsky L, Karpov I, et al. Individual quality of life in chronic kidney disease: Influence of age and dialysis modality. Clin J Am Soc Nephrol 2009; 4:711-718.
26. Kadam U. Redesigning the general practice consultation to improve care for patients with multimorbidity. BMJ 2012; 345:e6202.
27. The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2.0. The ADAPTE Collaboration 2010. Available from http://www.g-i-n.net/ document-store/working-groups-documents/adaptation/adapte-resourcetoolkit- guideline-adaptation-2-0.pdf/view?searchterm=adapte%202.0 [Accessed 13 June 2016].
28. Harrison MB, Graham ID, van den Hoek J, et al. Guideline adaptation and implementation planning: A prospective observational study. Implement Sci 2013; 8:49.
29. Mair FS, May CR. Thinking about the burden of treatment. BMJ 2014; 349:g6680.
30. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ 2009; 339:b2803.
31. LM, Larsen LP, Jessen A, et al. AmbuFlex: Tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases. Qual Life Res 2016; 25:525-534.
32. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004; 39:1005-1026.
33. Zimmerman L, Welch JL, et al. Patient activation with knowledge, self-management and confidence in chronic kidney disease. J Ren Care 2016; 42:15-22.
34. Gerber LM, Barron Y, Mongoven J, et al. Activation among chronically ill older adults with complex medical needs: Challenges to supporting effective selfmanagement. J Ambul Care Manage 2011; 34:292-303.
35. Fraser SD, Roderick PJ, Casey M, et al. Prevalence and associations of limited health literacy in chronic kidney disease: A systematic review. Nephrol Dial Transplant 2013; 28:129-137.
36. Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 2013; 13:211.